Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease

Leishmaniasis affects approximately 2 million people each year throughout the world. This high incidence is due in part to the lack of an efficacious vaccine. We present evidence that the recombinant leishmanial antigens LmSTI1 and TSA, which we identified and characterized previously, induce excell...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Campos-Neto, Antonio, Porrozzi, Renato, Greeson, Kay, Coler, Rhea N., Webb, John R., Seiky, Yasir A. W., Reed, Steven G., Grimaldi, Gabriel
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2001
Materias:
Fungal and Parasitic Infections
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC98475/
https://ncbi.nlm.nih.gov/pubmed/11349082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.6.4103-4108.2001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares